Next Article in Journal
Integrating Mental and Physical Health Care for Low-Income Americans: Assessing a Federal Program’s Initial Impact on Access and Cost
Next Article in Special Issue
Through the Patients’ Eyes: The Experience of End-Stage Renal Disease Patients Concerning the Provided Nursing Care
Previous Article in Journal
Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

End Stage Renal Disease—A Nephrologist’s Perspective of Two Different Circumstances as Typified by Kidney Transplantation Experience in a Nigerian Hospital Versus a Large US Medical School

by
Macaulay Amechi Chukwukadibia Onuigbo
1,2,3
1
Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
2
Department of Nephrology, Mayo Clinic Health System, Eau Claire, WI 54702, USA
3
College of Business, University of Wisconsin MBA Consortium, Eau Claire, WI 54701, USA
Healthcare 2017, 5(3), 31; https://doi.org/10.3390/healthcare5030031
Submission received: 28 May 2017 / Revised: 29 June 2017 / Accepted: 3 July 2017 / Published: 11 July 2017
(This article belongs to the Special Issue The Socio-Economic Impact of End Stage Kidney Disease)

Abstract

Renal transplantation is the sine qua non consummate form of renal replacement therapy (RRT) for end stage renal disease (ESRD). Despite the increasing ESRD burden worldwide, developing countries continue to experience a gross lack of RRT options for its teeming citizens with ESRD. This report is a demonstration of a nephrologist’s experience and dilemma trying to make sense of the yawning disparity between RRT options, especially renal transplantation, as it applies to the citizens of the USA versus the citizens of Nigeria. The limited three-year experience of renal transplantation at Garki Hospital, located in Abuja, the capital of Nigeria, which is one of the very few centers carrying out renal transplantation in Nigeria, was starkly contrasted with this author’s first-hand experience at the University of Maryland Medical School, in Baltimore, Maryland, USA, as a Nephrology Fellow between 2000 and 2002. The potential role of public-private partnership (PPP) ventures in developing countries is considered as a way to help bridge this gap.
Keywords: end stage kidney disease; Garki Hospital; Abuja; Nigeria; hemodialysis; peritoneal dialysis; public-private partnership (PPP); quality of life; renal replacement therapy (RRT); United States of America (USA); University of Maryland Medical School (UMMS) end stage kidney disease; Garki Hospital; Abuja; Nigeria; hemodialysis; peritoneal dialysis; public-private partnership (PPP); quality of life; renal replacement therapy (RRT); United States of America (USA); University of Maryland Medical School (UMMS)

Share and Cite

MDPI and ACS Style

Onuigbo, M.A.C. End Stage Renal Disease—A Nephrologist’s Perspective of Two Different Circumstances as Typified by Kidney Transplantation Experience in a Nigerian Hospital Versus a Large US Medical School. Healthcare 2017, 5, 31. https://doi.org/10.3390/healthcare5030031

AMA Style

Onuigbo MAC. End Stage Renal Disease—A Nephrologist’s Perspective of Two Different Circumstances as Typified by Kidney Transplantation Experience in a Nigerian Hospital Versus a Large US Medical School. Healthcare. 2017; 5(3):31. https://doi.org/10.3390/healthcare5030031

Chicago/Turabian Style

Onuigbo, Macaulay Amechi Chukwukadibia. 2017. "End Stage Renal Disease—A Nephrologist’s Perspective of Two Different Circumstances as Typified by Kidney Transplantation Experience in a Nigerian Hospital Versus a Large US Medical School" Healthcare 5, no. 3: 31. https://doi.org/10.3390/healthcare5030031

APA Style

Onuigbo, M. A. C. (2017). End Stage Renal Disease—A Nephrologist’s Perspective of Two Different Circumstances as Typified by Kidney Transplantation Experience in a Nigerian Hospital Versus a Large US Medical School. Healthcare, 5(3), 31. https://doi.org/10.3390/healthcare5030031

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop